Richard T. Woolf

St John's Institute Of Dermatology, Guy's And St Thomas' NHS Foundation Trust
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Apruritic Scabies Presenting on IL-31 Blockade with Nemolizumab: A Case Report.

Apruritic Scabies Presenting on IL-31 Blockade with Nemolizumab: A Case Report.

Journal: Clinical and experimental dermatology
Published: March 15, 2026

Healthcare resource use, costs and health-related quality of life in the UK-Irish Atopic eczema Systemic Therapy Register (A-STAR): a pilot study.

Healthcare resource use, costs and health-related quality of life in the UK-Irish Atopic eczema Systemic Therapy Register (A-STAR): a pilot study.

Journal: Skin health and disease
Published: February 17, 2026

PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasis.

PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasis.

Journal: BMJ open
Published: October 10, 2025

Effect of Delgocitinib Cream on Health-Related Quality of Life in Patients With Moderate to Severe Chronic Hand Eczema.

Effect of Delgocitinib Cream on Health-Related Quality of Life in Patients With Moderate to Severe Chronic Hand Eczema.

Journal: Contact dermatitis
Published: October 08, 2025

Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.

Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.

Journal: BMJ open
Published: August 21, 2025

Development of a PsA-like presentation under anti-IL-13 therapy with tralokinumab for atopic dermatitis.

Development of a PsA-like presentation under anti-IL-13 therapy with tralokinumab for atopic dermatitis.

Journal: Rheumatology (Oxford, England)
Published: August 20, 2025

Pharmacokinetic-pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real-world data.

Pharmacokinetic-pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real-world data.

Journal: British journal of clinical pharmacology
Published: July 23, 2025

Response to Lavin et al (2025)'s Paper: Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System.

Response to Lavin et al (2025)'s Paper: Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System.

Journal: The Journal of investigative dermatology
Published: March 28, 2025

Alpha-1 Antitrypsin Deficiency-Associated panniculitis: A survey of lived experience.

Alpha-1 Antitrypsin Deficiency-Associated panniculitis: A survey of lived experience.

Journal: PloS one
Published: January 30, 2025

The UK-Irish Atopic eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohort.

The UK-Irish Atopic eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohort.

Journal: The British journal of dermatology
Published: December 19, 2024

Personalizing Biologic Therapy in Psoriasis: Development, Validation, and User Testing of a Precision-Dosing Dashboard.

Personalizing Biologic Therapy in Psoriasis: Development, Validation, and User Testing of a Precision-Dosing Dashboard.

Journal: The Journal of investigative dermatology
Published: November 27, 2024

The management of severe eczema in pregnancy.

The management of severe eczema in pregnancy.

Journal: Clinical medicine (London, England)
Published: November 04, 2024
Showing 1-12 of 37

Last Updated: 09/26/2026